SORENSEN MEL (President and CEO) sold 26.4% of their position (70K shares) of GALERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2025ACC: 0000905148-25-004171
DirectorOfficer· President and CEO
Since Nov 2019
-70K
Net shares
Net seller
$1.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
70K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−70K
Price / share
$0.02
Trade value
$1.41K
% of position
26.4%
11/20/2025
265.03K→195.03K
Total
Net shares
−70K
Net value
-$1.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2025 | S · Sale | −70K | $0.02 | $1.41K | 26.4% | 265.03K | 195.03K |
| Total | −70K | -$1.41K | ||||||
Derivative Transactions0
No derivative transactions reported